The Effect of Interpersonal Psychotherapy on Quality of Life Among People Living With HIVAIDS
Sponsor
Mattu University (Other)
Overall Status
Completed
CT.gov ID
NCT06014671
Collaborator
(none)
128
1
2
1.9
66
Study Details
Study Description
Brief Summary
Quality of life (QOL) is a significant importance for people living with HIV/AIDS by modifying the adverse psychosocial consequences that accompany the disease. In Ethiopia, interpersonal psychotherapy (IPT) has never been tried for people living with HIV/AIDS for quality of life. The objective of the study was to assess the effects of interpersonal psychotherapy on quality of life among PLWHA at Mettu Karl referral and Bedele hospital, southwest Ethiopia, 2022.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
128 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The Effect of Interpersonal Psychotherapy on Quality of Life Among People Living With HIVAIDS at Mettu Karl Referral and Bedele Hospital, Southwest Ethiopia, 2022: A Quasi-experimental Study
Actual Study Start Date
:
Apr 1, 2022
Actual Primary Completion Date
:
May 30, 2022
Actual Study Completion Date
:
May 30, 2022
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Intervention group intervention group were took interpersonal psychotherapy |
Behavioral: Interpersonal Psychotherapy
Intervention Group were took interpersonal psychotherapy
|
| Experimental: Control group control group didn't took interpersonal psychotherapy |
Behavioral: Interpersonal Psychotherapy
Intervention Group were took interpersonal psychotherapy
|
Outcome Measures
Primary Outcome Measures
- The effect of Interpersonal Psychotherapy on quality of life among people living with HIVAIDS [two months]
Quality of Life measured by World Health Organization Health Related Quality of Life (WHOQOL- BREF).
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 59 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- PLWHA who were 18 years of age or above were included in the study
Exclusion Criteria:
- PLWHA who are either currently or previously used IPT and acute physical or mental disturbances will be excluded
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Mattu University | Addis Ababa | Oromia | Ethiopia | 318 (mattu) |
Sponsors and Collaborators
- Mattu University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Zakir Abdu,
Assistant Professor of Psychiatry,
Mattu University
ClinicalTrials.gov Identifier:
NCT06014671
Other Study ID Numbers:
- CHS/54/2014
First Posted:
Aug 28, 2023
Last Update Posted:
Aug 28, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No